Gilead Sciences Announces Second Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Gilead Sciences (GILD) Tops Q2 EPS by 6c, Offers Guidance
August 2, 2022 4:03 PM EDTGilead Sciences (NASDAQ: GILD) reported Q2 EPS of $1.58, $0.06 better than the analyst estimate of $1.52. Revenue for the quarter came in at $6.3 billion versus the consensus estimate of $5.86 billion.
GUIDANCE:
Gilead Sciences sees FY2022 EPS of $6.35-$6.75, versus the consensus of... More
